Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Feb;74(2):95-104.
doi: 10.1038/s41429-020-00366-2. Epub 2020 Sep 8.

Novel antimicrobial development using genome-scale metabolic model of Gram-negative pathogens: a review

Wan Yean Chung  1 , Yan Zhu  2 , Mohd Hafidz Mahamad Maifiah  3 , Naveen Kumar Hawala Shivashekaregowda  4 , Eng Hwa Wong  5 , Nusaibah Abdul Rahim  6
Affiliations
Review

Novel antimicrobial development using genome-scale metabolic model of Gram-negative pathogens: a review

Wan Yean Chung et al. J Antibiot (Tokyo). 2021 Feb.

Abstract

Antimicrobial resistance (AMR) threatens the effective prevention and treatment of a wide range of infections. Governments around the world are beginning to devote effort for innovative treatment development to treat these resistant bacteria. Systems biology methods have been applied extensively to provide valuable insights into metabolic processes at system level. Genome-scale metabolic models serve as platforms for constraint-based computational techniques which aid in novel drug discovery. Tools for automated reconstruction of metabolic models have been developed to support system level metabolic analysis. We discuss features of such software platforms for potential users to best fit their purpose of research. In this work, we focus to review the development of genome-scale metabolic models of Gram-negative pathogens and also metabolic network approach for identification of antimicrobial drugs targets.

PubMed Disclaimer

References

    1. World Health Organization. Antimicrobial resistance: global report on surveillance 2014. 2016:257. https://apps.who.int/iris/bitstream/handle/10665/112642/9789241564748_en... .
    1. World Health Organization. Global strategy for containment of antimicrobial resistance. 2001. https://apps.who.int/iris/bitstream/handle/10665/66860/WHO_CDS_CSR_DRS_2... .
    1. Jubeh B, Breijyeh Z, Karaman R. Antibacterial prodrugs to overcome bacterial resistance. Molecules. 2020;25. https://doi.org/10.3390/molecules25071543 .
    1. Giraldi G, Montesano M, Napoli C, Frati P, La Russa R, Santurro A, et al. Healthcare-associated infections due to multidrug-resistant organisms: a surveillance study on extra hospital stay and direct costs. Curr Pharm Biotechnol. 2019;20:643–52. https://doi.org/10.2174/1389201020666190408095811 . - DOI - PubMed
    1. Khan HA, Baig FK, Mehboob R. Nosocomial infections: epidemiology, prevention, control and surveillance. Asian Pac J Trop Biomed. 2017;7:478–82. https://doi.org/10.1016/j.apjtb.2017.01.019 . - DOI

Publication types

MeSH terms

Substances

LinkOut - more resources